(19) |
 |
|
(11) |
EP 0 553 604 A3 |
(12) |
EUROPEAN PATENT APPLICATION |
(88) |
Date of publication A3: |
|
06.10.1993 Bulletin 1993/40 |
(43) |
Date of publication A2: |
|
04.08.1993 Bulletin 1993/31 |
(22) |
Date of filing: 07.10.1992 |
|
|
(84) |
Designated Contracting States: |
|
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE |
(30) |
Priority: |
07.10.1991 SE 9102890
|
(71) |
Applicant: BAKER NORTON PHARMACEUTICALS, INC. |
|
Miami, Florida 33178 (US) |
|
(72) |
Inventor: |
|
- Evers, Hans
S-151 59 Södertälje (SE)
|
(74) |
Representative: Karlsson, Leif Karl Gunnar et al |
|
H.W. Barnieske Patentbyra AB
P.O. Box 25 S-151 21 Södertälje S-151 21 Södertälje (SE) |
|
|
|
|
|
Remarks: |
|
A request for correction of description, claims and abstract has been filed pursuant
to Rule 88 EPC. A decision on the request will be taken during the proceedings before
the Examining Division (Guidelines for Examination in the EPO, A-V, 2.2). |
|
(57) An insect repellant composition for against mosquitoes or other insects that attack
man and or warm-blooded animals contains up to 5 % by weight of a local anaesthetic
selected from the group comprising alkyl p-aminobenzoate (I), arylamide of 2-aminoacetic
acid (II), 2-aminoalkyl aryl ether (III), 2-aminoalkyl p-aminobensoate (IV) and mixtures
thereof. Particularly preferred is lidocaine and a mixture of lidocaine and prilocaine.